Concepts (69)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pre-Exposure Prophylaxis | 8 | 2024 | 196 | 1.300 |
Why?
|
| HIV Infections | 15 | 2024 | 5097 | 0.790 |
Why?
|
| Anti-HIV Agents | 8 | 2024 | 1324 | 0.660 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2024 | 256 | 0.400 |
Why?
|
| Adaptation, Psychological | 2 | 2019 | 26 | 0.320 |
Why?
|
| Homosexuality, Male | 2 | 2024 | 52 | 0.280 |
Why?
|
| Sexual and Gender Minorities | 2 | 2024 | 29 | 0.270 |
Why?
|
| Male | 13 | 2024 | 6754 | 0.270 |
Why?
|
| Social Stigma | 4 | 2024 | 80 | 0.270 |
Why?
|
| Adolescent | 9 | 2024 | 2985 | 0.270 |
Why?
|
| Qualitative Research | 3 | 2024 | 321 | 0.260 |
Why?
|
| South Africa | 13 | 2024 | 7596 | 0.240 |
Why?
|
| Adult | 12 | 2024 | 5913 | 0.240 |
Why?
|
| Young Adult | 8 | 2024 | 2498 | 0.240 |
Why?
|
| Female | 13 | 2024 | 9103 | 0.220 |
Why?
|
| Humans | 16 | 2024 | 14537 | 0.220 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2023 | 34 | 0.220 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2022 | 12 | 0.200 |
Why?
|
| Zimbabwe | 4 | 2023 | 120 | 0.200 |
Why?
|
| Uganda | 4 | 2023 | 197 | 0.190 |
Why?
|
| AIDS Vaccines | 1 | 2022 | 152 | 0.180 |
Why?
|
| HIV | 2 | 2022 | 380 | 0.170 |
Why?
|
| Attitude to Health | 2 | 2021 | 56 | 0.170 |
Why?
|
| Prescription Drug Misuse | 1 | 2019 | 2 | 0.160 |
Why?
|
| Resilience, Psychological | 1 | 2019 | 11 | 0.160 |
Why?
|
| HIV Seropositivity | 1 | 2021 | 265 | 0.160 |
Why?
|
| Substance-Related Disorders | 1 | 2019 | 51 | 0.160 |
Why?
|
| Anti-Retroviral Agents | 2 | 2019 | 551 | 0.150 |
Why?
|
| Logistic Models | 3 | 2024 | 254 | 0.130 |
Why?
|
| Treatment Refusal | 1 | 2015 | 13 | 0.120 |
Why?
|
| Disclosure | 1 | 2015 | 25 | 0.120 |
Why?
|
| HIV-1 | 2 | 2019 | 1260 | 0.110 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 1422 | 0.100 |
Why?
|
| Sexual Behavior | 2 | 2022 | 320 | 0.080 |
Why?
|
| Middle Aged | 3 | 2024 | 3601 | 0.080 |
Why?
|
| Counseling | 2 | 2019 | 143 | 0.070 |
Why?
|
| Social Support | 2 | 2019 | 77 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2019 | 1160 | 0.060 |
Why?
|
| Machine Learning | 1 | 2024 | 22 | 0.060 |
Why?
|
| Transgender Persons | 1 | 2024 | 24 | 0.060 |
Why?
|
| Kenya | 1 | 2024 | 183 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2024 | 112 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2024 | 225 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2024 | 203 | 0.050 |
Why?
|
| Medication Adherence | 1 | 2024 | 151 | 0.050 |
Why?
|
| Africa South of the Sahara | 1 | 2024 | 353 | 0.050 |
Why?
|
| Community Participation | 1 | 2022 | 42 | 0.050 |
Why?
|
| Africa, Southern | 1 | 2022 | 91 | 0.050 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 563 | 0.050 |
Why?
|
| Risk-Taking | 1 | 2022 | 121 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2024 | 967 | 0.050 |
Why?
|
| Heterosexuality | 1 | 2021 | 30 | 0.050 |
Why?
|
| Risk Factors | 1 | 2024 | 1475 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2022 | 1479 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2019 | 303 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 435 | 0.040 |
Why?
|
| Aged | 1 | 2022 | 1740 | 0.040 |
Why?
|
| Social Isolation | 1 | 2015 | 5 | 0.030 |
Why?
|
| Viral Load | 1 | 2019 | 819 | 0.030 |
Why?
|
| Asymptomatic Infections | 1 | 2015 | 34 | 0.030 |
Why?
|
| Pregnancy | 2 | 2018 | 1862 | 0.030 |
Why?
|
| Pregnancy in Diabetics | 1 | 1987 | 2 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 1987 | 25 | 0.020 |
Why?
|
| Blood Glucose | 1 | 1987 | 107 | 0.020 |
Why?
|
| Self Care | 1 | 1987 | 14 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1987 | 22 | 0.000 |
Why?
|
| Insulin | 1 | 1987 | 73 | 0.000 |
Why?
|
| Infant Mortality | 1 | 1987 | 97 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1987 | 139 | 0.000 |
Why?
|